SURF - Surface Oncology EPS in-line misses on revenue March, 10 2020 06:22 AM Surface Oncology Inc. Surface Oncology (NASDAQ:SURF): Q4 GAAP EPS of -$0.57 in-line.Revenue of $0.44M (-95.5% Y/Y) misses by $1.11M.Press ReleaseMore news on: Surface Oncology, Inc., Earnings news and commentary, Healthcare stocks news, ,